CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. ERAS
4. TREX
5. BAC
6. SPCX
7. SPY
8. WFC
9. SPRO
10. SKHY

Go back to CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.16 -0.06 (4.92%)
Previous Close $1.22    52 Week High $0.66 
Open $1.23    52 Week Low $0.20 
Day High $1.24    P/E N/A 
Day Low $1.14    EPS $-0.34 
Volume 97,714       

CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.16 -0.06 (4.92%)
Previous Close $1.22    52 Week High $0.66 
Open $1.23    52 Week Low $0.20 
Day High $1.24    P/E N/A 
Day Low $1.14    EPS $-0.34 
Volume 97,714